The NGC’s decision was based on the IDSA’s claim that its antitrust review process in 2009 fulfilled NGC review requirements. We strongly disagree. (Read why here.)
The NGC needs to remove the IDSA 2006 Lyme guidelines listing until they have been fully reviewed and revised. The IDSA needs to review its guidelines in an open and transparent process that includes both patient advocacy representatives and physicians who treat chronic Lyme disease, reflects the current state of the science, and complies with GRADE–a rigorous assessment standard that the IDSA adopted for guidelines reviewed after 2008. If you agree, sign the petition to let them know!